Dechra has launched Felimazole Oral Solution 5mg/ml (thiamazole) for the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy and for the long-term treatment of feline hyperthyroidism.

The new presentation is honey-flavoured and is available…

Dechra is running a series of six 30-45 minute webinars about Cushing's in dogs, starting on Tuesday 10th December.

The webinars are primarily aimed at veterinary surgeons, but there was a good turnout of nurses at the Cushing's session at the London…

Dechra is holding ‘Preventive strategies for strangles: linking research to action’, a free one-hour webinar to help veterinary professionals translate the latest equine strangles surveillance data and research into everyday veterinary practice…

Dechra has announced four CPD sessions it will be hosting at the London Vet Show on 14th and 15th November.

• 11:00 to 11:50 on the 14th: ‘The three things about Cushing’s I wish I’d known sooner’, presented by Emily Casey BVM&S MRCVS, veterinary technical…

Dechra has launched Furosoral for the initial treatment or maintenance therapy of conditions associated with fluid build-up in cats and dogs.

Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and…

Dechra has announced its acquisition of a Invetx, a biotech company. 

Invetx specialises in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).

Dechra says these therapies have…

Dechra has launched Lodisure, a 1mg chicken-flavoured amlodipine tablet for the treatment of feline hypertension. 

Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.

The recommended starting dose…

Dechra is hosting a one-hour canine otitis externa webinar at 7:00pm on Wednesday 31st July to share practical tips on otitis externa, how to choose the right treatments and the latest guidelines for using antibiotics responsibly.

The ‘Ear essentials…

Dechra has launched ‘They’ve got Cushing’s. You’ve got us’ marketing campaign to highlight the company’s support for Vetoryl.

Across Europe, the company has over 30 technical experts who get over 2,500 technical calls…

Dechra has launched a Cushing’s treatment and monitoring app to support owners prescribed Vetoryl for their dog.

The free app is designed to help to track changes and improvements in a dog’s health during treatment. 

The app uses questionnaires…

Dechra has launched Pergocoat, for the treatment of Pituitary Pars Intermedia Dysfunction (PPID), aka equine Cushing’s disease.

Pergocoat contains pergolide, a long-acting dopamine receptor agonist.

It is available in 0.5mg (off-white) and 1mg (yellow…

Dechra has sponsored two hour-long sessions at this year's Virtual Veterinary Conference 2024, which is free of charge and takes place from Monday 5th to Friday 9th February.

The first, hosted by Sam Taylor, head of veterinary specialists at ISFM (International…

Dechra (the maker of Vetoryl) has launched 'Prime Suspects', a nationwide campaign to raise awareness of Cushing’s syndrome amongst dog owners and drive them to vet practices for diagnosis and treatment.

The company points to a survey of 1000…

Dechra has created a new app with the Royal Veterinary College which promises to help vets better diagnose and treat endocrine disorders in companion animals. 

Typically, diagnosis of endocrine disease is based on a thorough history and physical examination…

Dechra will be hosting two CPD sessions at the London Vet Show, the first about why senior cat health checks are worthwhile and the second covering the Nordic approach to antibiotic usage in otitis external.

‘Feline enthusiasts assemble! How to help senior…

Dechra has launched a range of resources to provide veterinary professionals and owners with education, tips and support to achieve better clinical outcomes and owner satisfaction for dogs with otitis externa.

The 'Lifelong Ear Partnership' resources,…

Dechra has launched Equisolon Jar, a new presentation of its oral prednisone powder for the treatment of severe equine asthma.

Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters…

Dechra has published the results of a survey which shows how vets and horse owners could do more to prevent strangles. 

The survey of 50 vets carried out in May this year¹ found that only half of them are recommending strangles vaccination to their clients…

Dechra has taken over the distribution of two products designed to support kidney health in senior cats, Porus One and its sister product Add One.

Porus One contains renaltec, a selective absorber that absorbs the precursors of uraemic toxins in the cat…

Dechra, the maker of Mirataz, is hosting a free webinar: ‘Feline pawsative about feline inappetence?’, at 8:00pm tonight.

Presented by Sam Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, the webinar will also be available to watch on…

Dechra has relaunched Sedaxylan 20 mg/ml solution for the sedation and premedication prior to general anaesthesia of dogs, cats, horses and cattle.

Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for I/V administration…

Dechra has launched Zenalpha, an alpha-2 agonist and peripheral antagonist combination to alleviate the stress of sedation in dogs and maintain the stability of physiological parameters¹.

Zenalpha provides restraint, sedation and analgesia during non…

Dechra has launched Dexacortone (dexamethasone 0.5 mg and 2 mg), a long-acting glucocorticosteroid for the symptomatic treatment of inflammatory and allergic conditions in cats and dogs.

Dechra says that Dexacortone, which is presented as a flavoured double…

Dechra has launched Equibactin Powder (25mg sulfadiazine and 5mg trimethoprim), a new antibiotic powder designed to help prevent the under-dosing of larger horses being treated for bacterial infections.

Equibactin oral powder comes in a 60g sachet, which…

Dechra has launched a 9g sachet version of its prednisolone treatment, Equisolon, for horses with severe equine asthma.

The oral corticosteroid powder formulation was previously only available in 180g tubs.

Severe equine asthma, which was previously known…